[1]逄宇,夏辉,姜广路,等. 中国结核分枝杆菌寡核苷酸基因分型及其耐药性分析. 中华检验医学杂志, 2011, 34(11):1023-1028.[2]Wade MM, Zhang Y. Mechanisms of drug resistance in Mycobacterium tuberculosis. Front Biosci, 2004, 9: 975-994. [3]Bolotin S, Alexander DC, Chedore P, et al. Molecular characterization of drug-resistant Mycobacterium tuberculosis isolates from Ontario, Canada. J Antimicrob Chemother, 2009, 64(2): 263-266. [4]Louw GE, Warren RM, Gey van Pittius NC, et al. A balancing act: efflux/influx in mycobacterial drug resistance. Antimicrob Agents Chemother, 2009, 53(8): 3181-3189. [5]Somoskovi A, Parsons LM, Salfinger M. The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis. Respir Res, 2001, 2(3): 164-168. [6]Ma X, Wang H, Deng Y, et al. rpoB Gene mutations and molecular characterization of rifampin-resistant Mycobacterium tuberculosis isolates from Shandong Province, China. J Clin Microbiol, 2006, 44(9): 3409-3412. [7]Leonard B, Coronel J, Siedner M, et al. Inter- and intra-assay reproducibility of microplate Alamar blue assay results for isoniazid, rifampicin, ethambutol, streptomycin, ciprofloxacin, and capreomycin drug susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol, 2008, 46(10): 3526-3529.[8]Gupta AK, Katoch VM, Chauhan DS, et al. Microarray analysis of efflux pump genes in multidrug-resistant Mycobacterium tuberculosis during stress induced by common anti-tuberculous drugs. Microb Drug Resist, 2010, 16(1): 21-28.[9]李桂莲, 王撷秀, 谢彤, 等. 药物外排泵基因表达与结核分枝杆菌耐药关系的探讨. 中华检验医学杂志, 2011, 34(7): 605-611.[10]Baysarowich J, Koteva K, Hughes DW, et al. Rifamycin antibiotic resistance by ADP-ribosylation: Structure and diversity of Arr. Proc Natl Acad Sci U S A, 2008, 105(12): 4886-4891.[11]孙勇, 李传友, 许绍发. 结核分枝杆菌耐药机制的研究进展. 国际呼吸杂志, 2010, 30(24): 1501-1505.[12]崔运勇, 王峰, 刘小立, 等. 深圳市耐多药结核分枝杆菌流行株耐药基因序列分析. 中国防痨杂志, 2011, 33(5): 257-262.[13]王海英, 徐勇, 邓云峰, 等. 山东省耐利福平结核分枝杆菌rpoB基因突变的研究. 中国防痨杂志, 2005, 27(5): 289-292.[14]胡志东, 张雪莲, 王洪海. 结核分枝杆菌外排泵及其抑制剂的研究进展. 中国感染控制杂志, 2010, 9(4): 294-296.[15]Liu J, Takiff HE, Nikaido H. Active efflux of fluoroquinolones in Mycobacterium smegmatis mediated by LfrA, a multidrug efflux pump. J Bacteriol, 1996, 178(13): 3791-3795.[16]Pasca MR, Guglierame P, Arcesi F, et al. Rv2686c-Rv2687c-Rv2688c, an ABC fluoroquinolone efflux pump in Mycobacterium tuberculosis. Antimicrob Agents Chemother, 2004, 48(8): 3175-3178. [17]Pasca MR, Guglierame P, De Rossi E, et al.mmpL7 gene of Mycobacterium tuberculosis is responsible for isoniazid efflux in Mycobacterium smegmatis. Antimicrob Agents Chemother, 2005, 49(11): 4775-4777. [18]Colangeli R, Helb D, Sridharan S, et al. The Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutol. Mol Microbiol, 2005, 55(6): 1829-1840.[19]Ramón-García S, Martin C, Thompson CJ, et al. Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth. Antimicrob Agents Chemother, 2009, 53(9): 3675-3682. [20]Jiang X, Zhang W, Zhang Y, et al. Assessment of efflux pump gene expression in a clinical isolate Mycobacterium tuberculosis by real-time reverse transcription PCR. Microb Drug Resist, 2008, 14(1): 7-11. [21]Malen H, De Souza GA, Pathak S, et al. Comparison of membrane proteins of Mycobacterium tuberculosis H37Rv and H37Ra strains. BMC Microbiol, 2011,11: 18. [22]Betts JC, Lukey PT, Robb LC, et al. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol Microbiol, 2002, 43(3): 717-731. |